相关实验视频
Updated: May 21, 2026

08:35
Production and Titering of Recombinant Adeno-associated Viral Vectors
Published on: November 27, 2011
对于复合腺相关病毒制造平台的过程和质量考虑
Min Tae Park1, Amrisha Verma1, Clifford A Froelich1
1BioProcess Sciences, Pharma Services, Viral Vector Services, Thermo Fisher Scientific, Plainville, MA 02762, USA.
Trends in biotechnology
|March 27, 2025
概括
本综述探讨了复合腺相关病毒 (AAV) 制造平台,详细介绍了转染,感染和生产细胞系. 它为为基因疗法开发选择最佳的AAV生产方法提供了见解.
科学领域:
- 生物技术是生物技术.
- 基因治疗 基因治疗
- 过程开发 过程开发
背景情况:
- 再组合腺相关病毒 (AAV) 是基因疗法的关键载体,因为它的安全性和有效性.
- 扩大AAV制造规模带来了重大挑战,包括复杂性,成本和质量控制.
研究的目的:
- 审查共同的AAV悬浮生产平台:转染,感染和稳定的生产细胞系 (PCL).
- 提供对每个平台的优势和挑战的见解,以加速流程开发和知情选择.
主要方法:
- 检查每个AAV生产平台的常见单元操作.
- 为关键操作参数提供典型范围.
- 包括高级别的产品质量规范.
主要成果:
- 详细分析传染,感染和PCL作为AAV制造平台的情况.
- 确定每个方法的常见单元操作和关键过程参数.
- 对AAV生产相关的产品质量规范的介绍.
结论:
- 了解每个AAV制造平台的细微差别对于流程优化至关重要.
- 根据临床使用和目标产品配置文件,明智地选择生产平台,可以加速AAV基因治疗的开发.
更多相关视频
相关概念视频
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

